The Effect of the Severity of COVID-19 Disease on the Incidence of Acute Renal Failure in ICU
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 158
- 试验地点
- 1
- 主要终点
- KDIGO criteria
研究概览
简要总结
Aim of the study is to determinate the frequency of acute renal failure in COVID-19 patients, its relationship with the severity of COVID-19 disease in ICU, and the ability to take precautions against these factors.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Cross Sectional
入排标准
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Patients hospitalized in the intensive care unit diagnosed with COVID-19 will include in the study.
排除标准
- •there is no exclusion criteria
结局指标
主要结局
KDIGO criteria
时间窗: 6 months
KDIGO Criteria stage 1: Increase in SCr by ≥ 0.3 mg/dL within 48 hours or increase in SCr 1.5 to 1.9 times baseline which is known or presumed to have occurred within the prior 7 days Stage 2: 2.0 to 2.9 multiplied by baseline SCr; Stage 3: 3.0 or more multiplied by baseline; increase in SCr ≥ 4.0 mg/dL; or beginning of renal replacement therapy regardless of a previous KDIGO stage.
BRESCIA-COVID RESPIRATORY SEVERITY SCALE (BCRSS) scores
时间窗: 6 months
The BCRSS score (between level 0-8) is calculated from "www.mdcalc.com/brescia-covid-respiratory-severity-scale-bcrss-algorithm" according to the severity of COVID disease , respiratory rate, PaO2 level, chest x-ray, and clinical status.
次要结局
未报告次要终点
研究者
ismail aytaç
medical doctor
Ankara City Hospital Bilkent